July 5, 2020Annals of OncologyOpen Access

Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆

View Full Paper

Ask AI

Bookmark

No abstract yet

We only have this paper's title and publication details.

ClinicalTrials.gov identifier: NCT01702571.

No takes yet. Share an insight, caveat, or question.

Montemurro et al. (2020) studied this question.

View Full Paper

Ask AI

Bookmark